SDC1 and salivary gland cancer: To our knowledge, there have been limited studies on the expression of syndecan-1 in salivary gland tumors and little information is available about its expression pattern in these lesions.14, 15 The purpose of this research was to evaluate and compare the immunoexpression of syndecan-1 in a variety of benign and malignant salivary gland tumors and to correlate its expression with clinicopathologic parameters.